Cullinan Therapeutics (CGEM) Current Taxes (2022 - 2023)
Cullinan Therapeutics (CGEM) posted quarterly Current Taxes of $4.2 million for Q1 2023, down 1.75% quarter-over-quarter from $4.3 million in Q4 2022.
Powered by 
Analysis
Cullinan Therapeutics (CGEM) Current Taxes (2022 - 2023) Analysis & Trends
Cullinan Therapeutics' Current Taxes history runs 2 years deep, the most recent figure standing at $4.2 million for Q1 2023.
- In Q1 2023, Current Taxes changed N/A year-over-year to $4.2 million; the TTM figure through Mar 2023 stood at $4.2 million (changed N/A YoY), while the FY2022 annual figure was $4.3 million, changed N/A from the prior year.
- Current Taxes for Q1 2023 stood at $4.2 million, down from $4.3 million in the prior quarter.
- The five-year high for Current Taxes was $46.5 million in Q2 2022, with the low at $4.2 million in Q1 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.87 Bn | 131.01 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.57 Bn | 77.57 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | 49.00 Mn |
| 4 | Moderna | 58.19 Bn | 53.05 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.07 Bn | 44.07 Bn | - | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | 76.32 Mn |
| 7 | Alnylam Pharmaceuticals | 35.38 Bn | 32.07 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | - |
| 9 | Insmed | 27.41 Bn | 26.25 Bn | 358.27 Mn | - |
| 10 | Cullinan Therapeutics | 1.37 Bn | 1.37 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2023 | 4.21 Mn |
| Dec 31, 2022 | 4.28 Mn |
| Sep 30, 2022 | 11.40 Mn |
| Jun 30, 2022 | 46.50 Mn |